Trade Star Group’s Pharmaceutical Industry Acquisition Making New Breakthrough—Trade Star and GSK Reaching Agreement to Acquire the Equity of Nanjing Meirui

2016-08-23 09:46:35

Trade Star Group’s Pharmaceutical Industry Acquisition Making New Breakthrough—Trade Star and GSK Reaching Agreement to Acquire the Equity of Nanjing Meirui

On July 4th, 2016, our company has made into an agreement with GSK regarding the acquisition of Nanjing Meirui Equity. After the transition, our company will own all equity of Nanjing Meirui, and the business owned by Nanjing Meirui will be operated by our company.

图片关键词

图片关键词

Dr. Li Chao--Chairman of Trade Star and Mr. Brett—Director of Global Business Development GSK

图片关键词

First from the left: Mr. Brett—Director of Global Business Development GSK; Second from the left: Mr. Dominique—GSK Project Manager; Third from the left: Mr. Li Chao—Chairman of Trade Star; Fourth from the left: Ms. Nicola—GSK Legal Advisor

Nanjing Meirui is located in Nanjing, a city with favorable geographical location and transportation. As one of the manufacturing sites of GSK in China, it owns an internationally advanced manufacturing quality management system, and well-trained and highly experienced staff. Drugs such as Sheniting (quick release), Sheniting (controlled release) and Naftopidil Tablets are welcomed by the doctors and patients due to their great quality. This successful acquisition is beneficial to perfecting the layout of Trade Star’s pharmaceutical industry block, significantly enhancing the Group’s overall technical level of manufacturing quality management, and further enriching the Group’s product line. Trade Star will develop itself continuously by making full use of Nanjing Meirui’s manufacturing capacity, technical advantages and staff’s expertise, aiming at providing quality drug products for the patients and offering long-term development and growth opportunities for its staff.


Xinhua Net

http://news.xinhuanet.com/health/2016-07/04/c_129114946.htm


CN-healthcare

http://www.cn-healthcare.com/article/20160705/content-483979.html


ZYZHAN (China Pharmaceutical Net)

http://www.zyzhan.com/news/detail/55263.html


Saibailan

http://toutiao.com/a6303456367555887362/